<DOC>
	<DOCNO>NCT00180466</DOCNO>
	<brief_summary>PROSPECT multi-center prospective registry Acute Coronary Syndromes ( ACS ) patient single double vessel coronary artery disease . Approximately 700 patient ACS enrol study site United States European Union .</brief_summary>
	<brief_title>PROSPECT : An Imaging Study Patients With Unstable Atherosclerotic Lesions</brief_title>
	<detailed_description>To identify patient present ACS image modality and/or serologic marker inflammation may aid identification non-flow obstructing lesion increase risk future acute coronary event . This study ascertain prevalence clinical significance non-flow obstructing lesion , subsequently result acute coronary event - define vulnerable plaque . The safety regional image non-culprit lesion ACS patient also assess .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>1 . Acute cardiac pain , angina equivalent , consistent unstable angina myocardial infarction , last great 10 minute duration within past 72 hour . 2 . Patient must evidence ACS require catheterization document presence one follow condition : 1 . Elevated enzyme ( CKMB troponin I troponin T great upper limit normal ) . 2 . ST depression &gt; 1 mm 2 contiguous lead measure 40 m J point , absence leave ventricular hypertrophy , bundle branch block , pace rhythm , preexcitation ECG artifacts confound condition . 3 . Transient ST elevation &gt; 1 mm 2 contiguous lead last &lt; 30 minute ( otherwise criterion ) . 4 . ST elevation myocardial infarction onset &gt; 24 hour previously , diagnose typical triad nitrate unresponsive chest pain last &gt; 30 minute , ST elevation &gt; 1 mm 2 contiguous lead new leave bundle branch block , rise fall CKMB isoenzymes . Key Clinical 1 . Patient document acute STsegment elevation myocardial infarction within past 24 hour . 2 . Known serum creatinine &gt; 2.5 mg/dl . 3 . Decompensated hypotension heart failure require intubation , inotropes , intravenous diuretic intraaortic balloon counterpulsation . 4 . Patient known hypersensitivity , allergy contraindication follow : aspirin , heparin , clopidogrel , ticlopidine contrast adequately premedicated . 5 . Presence cardiac implant ( i.e . implantable defibrillator ) ; however , prior implantation pacemaker biventricular pacemaker permit . 6 . Presence cardiogenic shock . 7 . Patient know leave ventricular ejection fraction &lt; 30 % . 8 . Refractory ventricular arrhythmia require either intravenous pharmacologic treatment defibrillator therapy ( e.g . ventricular tachycardia fibrillation ) . 9 . Acute conduction system disease require temporary pacemaker insertion . 10 . Patient recent ( within 6 month ) PCI unless patient undergo staged procedure dual vessel treatment . 11 . Patient medical illness ( i.e. , cancer congestive heart failure ) recent history substance abuse may cause noncompliance Investigational Plan , confound data interpretation associate anticipate limited life expectancy le one year.. 12 . Prior participation study patient currently enrol another investigational use device drug study reach primary endpoint . If patient enrol another study investigational , required visit trial must interfere conduct trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>drug elute stent</keyword>
	<keyword>stent</keyword>
	<keyword>angioplasty</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>total coronary occlusion</keyword>
	<keyword>coronary artery restenosis</keyword>
	<keyword>stent thrombosis</keyword>
	<keyword>vascular disease</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>coronary artery stenosis</keyword>
</DOC>